VTE is an international patient safety issue and a national clinical priority for the NHS
Launched July 2018, WTD Thrombosis Ambassador of the Year program is an exciting new program developed to recognize a passionate ambassador who is dedicated to building awareness about thrombosis in his/her community, region, country, and/or globally.
Thrombosis UK would like to thank long-serving Trustee, Paul Westerman, who is stepping down from his role with the charity after four years of support.
An innovative app that helps warfarin patients to self-test and stay fully connected to their care teams has recently been approved by NHS Digital to join the NHS App Library, alongside a range of patient health care apps.
The number of patients being readmitted to hospital in an emergency with potentially preventable conditions such as pneumonia and pressure sores has grown significantly in the last seven years, analysis from The Nuffield Trust think tank shows today.
Thrombosis UK was delighted to hear Jeremy Hunt, UK Minister for Health, highlight the need for VTE prevention in his opening speech at the ‘Global Action for Patient Safety’ conference with the World Health Organisation, attended by our Medical Lead, Professor Beverley Hunt.
Around 1,250 people in Wales each year are at risk of dying from Hospital Acquired Thrombosis (HAT), following admission to hospital for surgery or an acute medical illness.
Patients who have had their AF resolved remain at a high risk of stroke and should still be treated with anticoagulants.
Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.
England has been a world leader in blood clot awareness, coming top in a recent awareness poll by the global organisation, World Thrombosis Day.
However, quarterly data published by NHS England has again shown a
rise in the number of hospitals failing to meet required standards of
VTE risk assessment rates.